DoseVault
Metabolic Compound

Semaglutide

The GLP-1 pioneer for sustainable weight loss and cardiovascular health.

Scientific Overview

Extensively studied in the STEP clinical trials, Semaglutide (sold as Wegovy and Ozempic) has demonstrated up to 15% weight loss in adults. Ongoing research (2024-2026) highlights its potent cardiovascular benefits even in non-diabetic populations.

Key Research Benefits

  • ✓Significant weight loss
  • ✓Improved blood sugar control
  • ✓Reduces heart attack/stroke risk
  • ✓Strong appetite suppression

Potential Side Effects

⚠Nausea
⚠Vomiting
⚠Diarrhea
⚠Constipation
⚠Abdominal pain

Research Protocols

Common Dosages

Standard Titration

0.25 mg -> 2.4 mg
Weekly

“Titrate every 4 weeks (0.25, 0.5, 1.0, 1.7, 2.4)”

Note: Dosages listed are common research protocols found in peer-reviewed literature and clinical trials. Individual results and requirements may vary significantly in a research context.

Dose Calculator

🧮 Peptide Reconstitution Calculator

mg

Total amount of peptide in the vial.

mL

Volume of water used to mix.

mcg

Draw to this mark

10 Units

or 0.10 mL on a U-100 syringe

Concentration:2.50 mg/mL
Peptide per Unit:25.00 mcg/unit
*Always double-check your calculations. This tool is for educational purposes only.

Explore Semaglutide

Where to source

Vendors with public COAs that stock this category. Affiliate links are disclosed.

  • Limitless Life Nootropics
    FL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.
    COA: JanoshikAffiliate disclosed
    View vendor →
  • SwissChems
    60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.
    COA: JanoshikAffiliate disclosed
    View vendor →
  • Amino Club
    EU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.
    COA: Third-partyAffiliate disclosed
    View vendor →

Quick Explainer

“Semaglutide is a breakthrough GLP-1 receptor agonist that mimics the hormone responsible for feeling full. It has redefined weight management by providing consistent, lasting results while improving metabolic markers across the board.”

Stack Semaglutide with…

Curated stacking partners researched alongside Semaglutide. Each link opens a dedicated stack page with combined benefits, side-effect overlap, and half-life considerations.

Semaglutide by goal

Read Semaglutide's profile filtered through specific research goals.

Semaglutide for Fat LossSemaglutide for Recovery

Molecular Profile

linear
C187H291N45O59
31 AA Sequence

Quick Reference

Status
Research Compound
Category
Metabolic
Common Dosage
0.25 mg -> 2.4 mg
Weekly
Plasma decay
100%~3%@ 5× t½

t½ 7 d · ~3% remaining at 35 d

Strictly for research purposes. Not for human consumption.

Related tools

Medical Disclaimer

Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.